FDA Inspection
Partner Therapeutics, Inc.Partner Therapeutics, Inc. – FDA Inspection, Sep 16, 2022
Record Details
This FDA Inspection record concerns Partner Therapeutics, Inc., with an inspection on September 16, 2022, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Partner Therapeutics, Inc.
- Inspection Date
- September 16, 2022
- Product Type
- Drugs
View Company Profile
ID · 2f7fb539-8a12-49fd-9029-c48ca1211d48
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1179756
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
2- 21 CFR 600.80(c)(1)(i)Reporting Requirements - 15-day alert
- 21 CFR 600.80(c)(1)(ii)Reporting Requirements - 15-day alert follow up
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Partner Therapeutics, Inc.
1| Date | Classification | Office | Project area |
|---|---|---|---|
| December 4, 2024 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Partner Therapeutics, Inc.
- FDA Inspection 1257612 - 2024-12-04
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.